HKU and China Merchants Group Forge Partnership in Peptide Drug Innovation
The University of Hong Kong (HKU), the commercial wing represented by Versitech Limited, formalised a significant agreement with China Merchants Group (CMG) on peptide drug innovation and discovery on 27 November 2024.
Attendees included HKU President Prof Xiang Zhang and CMG Chairman Mr Jianmin Miao, highlighting the importance of collaboration in advancing healthcare solutions
请参阅英文版。